Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life
Author(s)
Busse P1, Craig TJ2, Radojicic C3, O'Connor M4, Christiansen S5, Ulloa J6, Danese S6, Andriotti T7, Audhya P7, Desai V7
1The Mount Sinai Hospital, New York, NY, USA, 2The Pennsylvania State University, Hershey, PA, USA, 3Duke University School of Medicine, Cary, NC, USA, 44Allergy, Asthma, & Immunology Relief of Charlotte, Charlotte, NC, USA, 5University of California San Diego, La Jolla, CA, USA, 6Outcomes Insights, Agoura Hills, CA, USA, 7KalVista Pharmaceuticals, Inc., Cambridge, MA, USA
Presentation Documents
OBJECTIVES: Hereditary angioedema (HAE) is a rare genetic disease associated with unpredictable attacks of tissue swelling. We examined the impact of the patients’ last treated HAE attack on physical and social components of quality of life (QoL) and the effect of early treatment.
METHODS: Patients with type I/II HAE completed an online survey. Participants were ≥12 years old and treated ≥1 HAE attack with an on-demand therapy in past 3 months. Physical and social QoL was assessed using modified Hereditary Angioedema Quality of Life Questionnaire.
RESULTS: Respondents included 80 adults and 14 adolescents; 54% taking long-term prophylaxis (LTP) and 46% using on-demand therapy only (OD). Fifty-five percent rated their attack severity as moderate and 16% as severe or very severe. Median (interquartile range) time from attack onset to on-demand treatment was 2 hours (1-5 hours), with 19% treating in <1 hour. Sixty-five (69%) patients (68% OD; 71% LTP) indicated that their last attack had a medium/severe impact on their energy level and 32 patients (34%) indicated their last attack prevented participation in social activities (35% OD; 35% LTP). Of the patients who treated their attack in <1 vs ≥5 hours, 56% and 70%, respectively, indicated their attack had a medium/severe impact on their energy level, and 22% and 42% reported it prevented participation in social activities. Isolation due to HAE attack was experienced by 35 (37%) patients (33% OD; 41% LTP; 28% if treated <1 hour). Thirty-seven (39%) of patients (44% OD; 35% LTP) felt like a burden to people around them because they needed help treating their attack.
CONCLUSIONS: These results indicated patients’ physical and social QoL was affected by their HAE attack, regardless of being on LTP. Attacks treated in <1 hour were associated with a lower impact on QoL, suggesting that education focused upon early attack treatment may be beneficial.
Conference/Value in Health Info
Value in Health, Volume 27, Issue 6, S1 (June 2024)
Code
PCR267
Topic
Patient-Centered Research, Study Approaches
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes, Prospective Observational Studies
Disease
No Additional Disease & Conditions/Specialized Treatment Areas, Rare & Orphan Diseases